Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-045268
Filing Date
2021-07-06
Accepted
2021-07-06 12:00:55
Documents
1
Period of Report
2021-07-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6415
  Complete submission text file 0001209191-21-045268.txt   7811
Mailing Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM
Business Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM 31 030 253 8800
Merus N.V. (Issuer) CIK: 0001651311 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MERUS N.V. YALELAAN 62 UTRECHT P7 3584 CM
Business Address
Bakker Lex (Reporting) CIK: 0001790343 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37773 | Film No.: 211073163